| Study |
Reference |
|
Bellet, 2015
|
Bellet F Exposure to aripiprazole during embryogenesis: a prospective multicenter cohort study. Pharmacoepidemiol Drug Saf 2015;24:368-80
|
|
Bruno, 2024
|
Bruno Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study. EClinicalMedicine 2024; 70:102531
|
|
Ellfolk (Controls exposed to FGA), 2021
|
Ellfolk Second-generation antipsychotic use during pregnancy and risk of congenital malformations. Eur J Clin Pharmacol 2021; 77:1737-1745
|
|
Ellfolk (Controls unexposed NOS), 2021
|
Ellfolk Second-generation antipsychotic use during pregnancy and risk of congenital malformations. Eur J Clin Pharmacol 2021; 77:1737-1745
|
|
Freeman, 2021
|
Freeman Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Arch Womens Ment Health 2021; 24:659-667
|
|
Habermann (Control exposed to FGA), 2013
|
Habermann F Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol 2013;33:453-62
|
|
Habermann (Control unexposed, disease free), 2013
|
Habermann F Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol 2013;33:453-62
|
|
Huybrechts (Controls unexposed, NOS), 2023
|
Huybrechts The impact of in-utero antipsychotic drug exposure on congenital malformations: An international cohort study Pharmacoepidemiol Drug Saf 2021; 30 Suppl 1:3-439 Huybrechts Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US. JAMA Psychiatry 2023; 80:156-166 Huybrechts Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA Psychiatry 2016; 73:938-46
|
|
Huybrechts (Controls unexposed, sick), 2023
|
Huybrechts The impact of in-utero antipsychotic drug exposure on congenital malformations: An international cohort study Pharmacoepidemiol Drug Saf 2021; 30 Suppl 1:3-439 Huybrechts Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US. JAMA Psychiatry 2023; 80:156-166 Huybrechts Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA Psychiatry 2016; 73:938-46
|
|
Ishikawa, 2024
|
Ishikawa Association between exposure to atypical antipsychotics during pregnancy and risk of miscarriage. Acta Psychiatr Scand 2024; 150:562-572
|
|
Park, 2018
|
Park Y Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. Am J Psychiatry. 2018 Jun 1;175(6):564-574
|
|
Paulus, 2013
|
Paulus W Is the use of aripiprazole safe during first trimester of pregnancy? Reprod Toxicol 2013;37:487
|
|
Raguideau, 2017
|
Raguideau F Exposition in utero à l'acide valproïque et aux autres traitements de l'épilepsie et des troubles bipolaires et risque de malformations congénitales majeures (MCM) en France Agence nationale de sécurité du médicament et des produits de santé 2015:1-116
|
|
Sadowski, 2013
|
Sadowski A Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study. BMJ Open 2013;3:
|
|
Sorensen, 2015
|
Sorensen MJ Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy. PLoS One 2015;10:e0132280
|
|
Straub, 2022
|
Straub Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders: A National Birth Cohort Study. JAMA Intern Med 2022; 182:522-533
|
|
Wang - UK cohort, 2021
|
Wang Association between antipsychotic use in pregnancy and the risk of gestational diabetes: Population-based cohort studies from the United Kingdom and Hong Kong and an updated meta-analysis. Schizophr Res 2021; 229:55-62
|
